You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 6, June 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book and Software Reviews
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Health Policy
 •Ophthalmology, Other
 •Alert me on articles by topic

Overdo$ed America: The Broken Promise of American Medicine

The Truth About the Drug Companies: How They Deceive Us and What to Do About It

Overdo$ed America: The Broken Promise of American Medicine by John Abramson, MD; 332 pp, $24.95, ISBN 0-06-056852-6, New York, NY, HarperCollins, 2004.
The Truth About the Drug Companies: How They Deceive Us and What to Do About It by Marcia Angell, MD; 305 pp, $24.95, ISBN 0-375-50846-5, New York, NY, Random House Inc, 2004.

Arch Ophthalmol. 2005;123:876-877.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Both books enumerate health care problems created by the pharmaceutical and biotechnology industries. Dr Abramson is a primary care physician who took time off to write his book, and Dr Angell is now a member of the Harvard Medical School’s Department of Social Medicine. She was the editor-in-chief of the New England Journal of Medicine. Each author lists the problems and proposes solutions. There are many commonalities, albeit different perspectives.

The lack of information that leads clinicians to deliver poor care is the most noisome for Dr Abramson, probably because he spent most of his career as a clinician. He delves into specific instances describing when information was manipulated to the detriment of his patients so that drugs would be sold and companies would profit. The statins (with exaggerated claims), COX-2 inhibitors (now in the news for drug-company suppression of known complications), high-dose chemotherapy and bone marrow transplantation (for . . . [Full Text of this Article]


AUTHOR INFORMATION
Samuel Packer, MD, Reviewer







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.